Nonoperating Income (Expense) of GlobeStar Therapeutics Corp from 30 Sep 2013 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
GlobeStar Therapeutics Corp quarterly and annual Nonoperating Income (Expense) in USD history and change rate from 30 Sep 2013 to 30 Jun 2024.
  • GlobeStar Therapeutics Corp Nonoperating Income (Expense) for the quarter ending 30 Jun 2024 was $4,304, a 33% decline year-over-year.
  • GlobeStar Therapeutics Corp Nonoperating Income (Expense) for the twelve months ending 30 Jun 2024 was $82,358, a 170% decline year-over-year.
  • GlobeStar Therapeutics Corp annual Nonoperating Income (Expense) for 2023 was $84,879, a 62% increase from 2022.
  • GlobeStar Therapeutics Corp annual Nonoperating Income (Expense) for 2022 was $222,745, a 69% increase from 2021.
  • GlobeStar Therapeutics Corp annual Nonoperating Income (Expense) for 2021 was $707,399.
Source SEC data
View on sec.gov
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

GlobeStar Therapeutics Corp Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $82,358 $4,304 -$1,058 -33% 01 Apr 2024 30 Jun 2024 10-Q 11 Oct 2024 2024 Q3
Q1 2024 $81,300 $7,379 +$799 +9.8% 01 Jan 2024 31 Mar 2024 10-Q 28 Jun 2024 2024 Q2
Q4 2023 $82,099 $7,888 +$2,780 +26% 01 Oct 2023 31 Dec 2023 10-Q 12 Mar 2024 2024 Q1
Q3 2023 $84,879 $62,787 -$54,322 -642% 01 Jul 2023 30 Sep 2023 10-K 19 Jan 2024 2023 FY
Q2 2023 $30,557 $3,246 +$18,239 +85% 01 Apr 2023 30 Jun 2023 10-Q 11 Oct 2024 2024 Q3
Q1 2023 $48,796 $8,178 +$18,070 +69% 01 Jan 2023 31 Mar 2023 10-Q 28 Jun 2024 2024 Q2
Q4 2022 $66,866 $10,668 +$155,879 +94% 01 Oct 2022 31 Dec 2022 10-Q 12 Mar 2024 2024 Q1
Q3 2022 $222,745 $8,465 01 Jul 2022 30 Sep 2022 10-K 19 Jan 2024 2023 FY
Q2 2022 $21,485 01 Apr 2022 30 Jun 2022 10-Q 17 Aug 2023 2023 Q3
Q1 2022 $26,248 01 Jan 2022 31 Mar 2022 10-Q 31 May 2023 2023 Q2
Q4 2021 $166,547 01 Oct 2021 31 Dec 2021 10-Q 13 Feb 2023 2023 Q1
Q2 2019 $53,319 +$74,584 01 Apr 2019 30 Jun 2019 10-Q 02 Aug 2019 2019 Q3
Q2 2018 $21,265 01 Apr 2018 30 Jun 2018 10-Q 02 Aug 2019 2019 Q3
Q2 2015 $60,020 +$295,846 +83% 01 Apr 2015 30 Jun 2015 10-Q/A 24 Sep 2015 2015 Q3
Q1 2015 $154,411 -$87,650 -131% 01 Jan 2015 31 Mar 2015 10-Q/A 17 Sep 2015 2015 Q2
Q2 2014 $355,866 01 Apr 2014 30 Jun 2014 10-Q/A 24 Sep 2015 2015 Q3
Q1 2014 $66,761 01 Jan 2014 31 Mar 2014 10-Q/A 17 Sep 2015 2015 Q2

GlobeStar Therapeutics Corp Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $84,879 +$137,866 +62% 01 Oct 2022 30 Sep 2023 10-K 19 Jan 2024 2023 FY
2022 $222,745 +$484,654 +69% 01 Oct 2021 30 Sep 2022 10-K 19 Jan 2024 2023 FY
2021 $707,399 01 Oct 2020 30 Sep 2021 10-K 09 Jan 2023 2022 FY
2014 $787,603 -$486,690 -162% 01 Oct 2013 30 Sep 2014 10-K/A 27 Jan 2015 2014 FY
2013 $300,913 01 Oct 2012 30 Sep 2013 10-K/A 27 Jan 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.